For her discovery, Neta Pessah received one of the prestigious Kaye Innovation Awards presented on June 9 during the Hebrew University Board of Governors meeting in Jerusalem.
Epilepsy is one of the most common neurological disorders, affecting about one percent of the world's population. Many new antiepileptic drugs have been introduced to the clinics recently, but despite the availability of these drugs, about 30 percent of the patients are still not seizure free.
Furthermore, many of the available drugs cause side effects, which can sometimes be fatal. One of the leading drugs for treating epilepsy and other neurological disorders is valproic acid (VPA). However, this drug has two life threatening side effects, liver toxicity and fetal malformation, that are related to the drug's chemical structure.
In Pessah’s ongoing research with VPA, she was successful in designing and synthesizing a new family of compounds based on a non-harmful analogue of that drug. Two of the compounds she formulated, Alpha-F-TMCD and Alpha-Cl-TMCD, were found to be highly potent as anticonvulsants without harmful side effects when tested on animal models. Alpha-Cl-TMCD is now under further testing at the National Institutes of Health in the United States.
Pessah says that her results suggest that these two novel compounds have high potential for development into new drugs to treat different types of epilepsy, neuropathic pain and other central nervous system disorders. The compounds have shown high potency, wide safety margins and lack of harmful effects on fetuses.
The Kaye Innovation Awards have been given annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society.
Jerry Barach | Hebrew University
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
Improving the understanding of death receptor functions in cells
07.11.2018 | Goethe-Universität Frankfurt am Main
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals
Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.
Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.
Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...
Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.
The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
10.12.2018 | Life Sciences
10.12.2018 | Physics and Astronomy
10.12.2018 | Life Sciences